Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Poor patient compliance and the spread of drug-resistant strains pose serious threats to anti-tuberculosis treatment regimens. In this Innovation article, Griffithset al. review the potential advantages of using biodegradable nanoparticles as delivery systems for anti-tuberculosis drugs and vaccines.
